Case Report: Clinical diagnosis and management of Carney syndrome complicated by occult primary peritoneal pseudomyxoma and ultra-rapid recurrence of cardiac myxoma
Carney Complex (CNC) is an extremely rare autosomal dominant hereditary multiple tumor syndrome characterized by skin pigmentation, cardiac and mucocutaneous myxomas, and endocrine adenomas. However, Carney Complex (CNC) complicated by pseudomyxoma peritonei (PMP) of lower gastrointestinal origin is extremely rare, posing a significant challenge for clinical diagnosis and multidisciplinary management. This report presents the complete diagnostic and treatment process of a young female CNC patient with a PRKAR1A gene mutation, aiming to thoroughly explore the diagnostic key points and individualized treatment strategies for this atypical, aggressive disease progression. The patient had a history of recurrent multisystem tumors and surgeries spanning more than a decade (including the eye, heart, breast, and adrenal glands) and was admitted to the hospital due to sudden acute abdominal symptoms. Preoperative imaging revealed a pelvic mass with massive effusion, and tumor markers (CEA, CA199) were abnormally elevated. Following surgical exploration and complete resection of the lesions, histopathology and immunohistochemistry (CK20+/CDX-2+/SATB-2+, PAX-8-/WT-1-) confirmed a low-grade mucinous tumor of lower gastrointestinal origin; however, the appendix showed only acute superficial inflammation, and the primary site remained highly occult, leading to a final diagnosis of PMP.Furthermore, during short-term postoperative follow-up, the patient experienced another “accelerated” malignant recurrence of cardiac myxoma (the fifth recurrence, occurring less than one year after the previous surgery). This case highlights that, in the advanced stages of CNC, its neoplastic lineage may expand across mesenchymal tissue to tumors of gastrointestinal epithelial origin. In the face of such highly complex, rare, and multifocal malignant tumors, the full-lifecycle involvement of a multidisciplinary team (MDT) is crucial for determining the optimal timing of surgery, assessing the risk of recurrence, and improving long-term patient survival. Future research should focus on the molecular mechanisms by which PRKAR1A mutations drive mucinous metaplasia in the gastrointestinal tract.
Authors
- Jun Xu (ORCID: https://orcid.org/0000-0002-4133-2533)
- Meiqi Li
- Panmengying Chen
- Tianyu Zhou
Institutions
- China Three Gorges University (CN)
- Yichang Central People's Hospital (CN)
Publication Details
- Journal
- Frontiers in Medicine
- Published
- 2026-11-17
- DOI
- https://doi.org/10.3389/fmed.2026.1949081
- Primary Topic
- Cardiac tumors and thrombi
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Natural Science Foundation of Hubei Province